Jointed cactus, 0puntia aurantiaca Lindley, remains a problem and continues to expand its range in South Africa, in spite of a mandatory herbicidal control. programme. The feasibility of biologically controlling the weed is being explored because the cost of herbicides has escalated and, if it succeeds, biological control is permanent self perpetuating and relatively cheap. This thesis describes the introduction and release in South Africa of the phycitid moth, Tucumania tapiacola Dyar, as a potential biocontrol agent against jointed cactus. A preliminary objective of the study was to resolve the taxonomic confusion within the genus Tucumania, so that the various populations of the moth from widespread localities and from different host plants could be identified. The efficiency of mass-producing T. tapiacola in the insectary was continually improved through investigations of the insects biology, and its response to various environmental parameters. Techniques were developed to manipulate the different life-stages of T. tapiacola so that every release was made with the maximum possible number of individuals, all in the same stage of development. Trials were made with various methods for transporting and releasing T. tapiacola in the field, and the most successful of these were employed during the establishment programme. In all, approximately 830 000 T. tapiacola eggs, larvae and adults have been released at seven localities in South Africa, between May 1977 and February 1982. So far, the moth has failed to establish for more than three to five generations at any release site, for reasons that were not immediately apparent. The mortality factors acting against the immature stages of T. tapiacola have been investigated and quantified. The accumulated data were used to construct partial-life-tables and survivorship curves. These show that survival of the eggs, larvae and pupae differed in shaded and exposed habitats, and on small, medium and large O. aurantiaca plants. The overall mortality suffered by the immature stages alone did not account for the establishment failure. Alternatively, genetic problems that are commonly associated with the collection, mass production and release of biocontrol agents may have been responsible for the failure. Methods of overcoming these problems during future releases are discussed.